LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
Overview
Share price change
24h
Current
Min
84.42
Max
85.99
Recommendations | Buy |
---|---|
12 Months Forecast | +32.79 upside |
Next Earnings | 5 sie 2024 |
---|
Technical Score
By Trading Central
Confidence
Bearish Evidence
84.25 / 85.97 Support & Resistance
BioNTech SE ADR Chart
Related News
6 maj 2024, 11:27 UTC
BioNTech Swings to Net Loss on Lower Covid Vaccine Sales
DJ
Read
20 mar 2024, 10:44 UTC
BioNTech Profit Slumps on Lower Covid Vaccine Sales
DJ
Read
8 lut 2024, 11:43 UTC
BioNTech Agrees To Invest $200 Million in Autolus, Starts Strategic Collaboration
DJ
Read
9 sty 2024, 19:42 UTC
BioNTech Shares Down 3.4%; Sees 2024 Revenue Below Wall Street Views
DJ
Read
19 gru 2023, 16:57 UTC
CureVac Shares Hit All-Time Low on German Patent Court Ruling
DJ
Read
13 gru 2023, 13:16 UTC
Moderna Shares, Other Covid Vaccine Makers Hit by Warning From Pfizer
DJ
Read
6 lis 2023, 19:07 UTC
Trending: BioNTech Reports Surprise Profit, Cuts Outlook
DJ
Read
6 maj 2024, 20:15 UTC
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come -- IBD
DJ
Read
6 maj 2024, 10:47 UTC
BioNTech Sees FY24 Rev EUR2.5B-EUR3.1B >BNTX
DJ
Read
6 maj 2024, 10:46 UTC
Correct: BioNTech 1Q Loss/Shr EUR1.31 >BNTX
DJ
Read
6 maj 2024, 10:46 UTC
Correct: BioNTech 1Q Loss EUR315.1M >BNTX
DJ
Read
6 maj 2024, 10:46 UTC
Correct: BioNTech 1Q Rev EUR187.6M >BNTX
DJ
Read
6 maj 2024, 10:45 UTC
BioNTech 1Q Rev $187.6M >BNTX
DJ
Read
6 maj 2024, 10:45 UTC
BioNTech 1Q Loss $315.1M >BNTX
DJ
Read
6 maj 2024, 10:45 UTC
BioNTech 1Q Loss/Shr $1.31 >BNTX
DJ
Read
26 mar 2024, 05:00 UTC
This Vaccine Maker Sits on Cash Almost Equal to Its Market Value -- Barrons.com
DJ
Read
20 mar 2024, 11:44 UTC
BioNTech Earnings Fall Short of Estimates. The Stock Is Down. -- Barrons.com
DJ
Read
20 mar 2024, 10:27 UTC
BioNTech's Stock Sinks After Earnings Fall Below Expectations, Hurt By Writedowns Of Vaccine Inventory -- MarketWatch
DJ
Read
20 mar 2024, 10:17 UTC
BioNTech 4Q Rev EUR1.48B >BNTX
DJ
Read
20 mar 2024, 10:15 UTC
Biontech 4Q Net Pft EUR457.9M
DJ
Read
20 mar 2024, 10:15 UTC
Biontech Plans For Ten or More Registrational Oncology Trials By End of 2024
DJ
Read
20 mar 2024, 10:15 UTC
Biontech: Annemarie Hanekamp appointed to Management Board as Chief Commercial Officer, effective Jul. 1
DJ
Read
20 mar 2024, 10:15 UTC
Biontech Aims For First Oncology Launch in 2026 and Ten Indication Approvals by 2030
DJ
Read
20 mar 2024, 10:15 UTC
Biontech 2023 Gross Profit For COVID-19 Vaccine Business EUR3.2B
DJ
Read
20 mar 2024, 10:15 UTC
Biontech Sees 2024 Revenue Between EUR2.5B - EUR3.1B
DJ
Read
20 mar 2024, 10:15 UTC
Biontech 4Q Rev EUR1.48B
DJ
Read
8 lut 2024, 11:28 UTC
BioNTech Agrees To Invest $200 Mln in Autolus, Starts Strategic Collaboration
DJ
Read
9 sty 2024, 19:27 UTC
BioNTech Shares Down 3.4%; Sees 2024 Rev Below Wall Street Views
DJ
Read
15 gru 2023, 16:44 UTC
Barron's Favorite 10 Stocks for 2024 -- -2-
DJ
Read
15 gru 2023, 16:44 UTC
Barron's Favorite 10 Stocks for 2024 -- Barrons.com
DJ
Read
Peer Comparison
Price change
BioNTech SE ADR Forecast
Price Target
By TipRanks
12 Months Forecast
Average 112.45 USD 32.79%
High 171 USD
Low 90 USD
Based on 13 Wall Street analysts offering 12 month price targets forBioNTech SE ADR - Dist in the last 3 months.
Rating Consensus
By TipRanks
Buy
13 ratings
5
Buy
7
Hold
1
Sell
Based on 13 analysts giving stock ratings to BioNTech SE ADR - Dist in the past 3 months.
Technical Score
By Trading Central
Short Term
Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Weak Bearish Evidence
There is one bearish event.
Long Term
Bearish Evidence
All events are bearish.